
Pharma Pulse 3/4/24: Local Pharmacies on the Brink, People in MA Plans Experienced Delays in Accessing Care & more
The latest news for pharma industry insiders.
In an interview with Associate Editor Don Tracy, Corey Ford, VP, Reimbursement & Policy Insights, Cencora, offers his thoughts on where the Inflation Reduction Act will be five to 10 years from now.
The Commonwealth Fund 2024 Value of Medicare Survey surveyed 3,280 Medicare beneficiaries about access to benefits, services, providers, care coordination, and satisfaction. The survey was conducted by SSRS for the Commonwealth Fund between Nov. 6, 2023, and Jan. 4, 2024 and found about two thirds of older Americans enrolled in Medicare Advantage or traditional plans say their coverage met expectations
A new antibody that protects babies from a deadly virus proved far more popular than drugmaker Sanofi expected
As rumors swirl in Washington, D.C., that lawmakers may once again be punting on PBM reform, the National Community Pharmacists Association recently released a survey showing many local pharmacies are running out of time.
Originally sanctioned for diabetes management as Ozempic, semaglutide's pivot toward weight loss promotion as Wegovy resulted in a surge in purchases and increased the IOP market share. Read more in IQVIA Institute’s report: https://bit.ly/49Rar0j. #Pharma
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.





